Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Journal of Clinical Microbiology|May 5, 2006
International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003)Shawn A Messer, Ronald N Jones, Thomas R FritscheAntimicrobial Agents and Chemotherapy|March 26, 2003
Drug resistance is not directly affected by mating type locus zygosity in Candida albicansClaude Pujol, Shawn A Messer, Michael Pfaller, et al.Diagnostic Microbiology and Infectious Disease|April 11, 2016
Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)Mariana Castanheira, Shawn A Messer, Paul R Rhomberg, et al.Mycoses|March 3, 2015
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012Michael A Pfaller, Mariana Castanheira, Shawn A Messer, et al.Antimicrobial Agents and Chemotherapy|January 6, 2017
Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance ProgramMichael A Pfaller, Shawn A Messer, Paul R Rhomberg, et al.Diagnostic Microbiology and Infectious Disease|February 22, 2020
In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018Shawn A Messer, Cecilia G Carvalhaes, Mariana Castanheira, et al.International Journal of Antimicrobial Agents|July 11, 2017
CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance ProgramMichael A Pfaller, Shawn A Messer, Paul R Rhomberg, et al.The Journal of Antibiotics|April 23, 2015
Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)Michael A Pfaller, Shawn A Messer, Ronald N Jones, et al.Journal of Clinical Microbiology|November 28, 2008
Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolatesShawn R Lockhart, Shawn A Messer, Michael A Pfaller, et al.Journal of Clinical Microbiology|April 24, 2009
Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)Shawn A Messer, Gary J Moet, Jeffrey T Kirby, et al.Pageof 7